Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

er GSK plc American Depositary Shares (GSK)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

21 disclosures
7 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
GSK / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

Lisa McClain, Representative

sell disclosed on 21 Nov 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 21 Nov 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

sell disclosed on 21 Nov 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Valerie Hoyle, Representative

sell disclosed on 10 Oct 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 12 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Valerie Hoyle, Representative

buy disclosed on 12 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Robert B. Aderholt, Representative

sell disclosed on 10 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

sell disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Bruce Westerman, Representative

sell disclosed on 12 May 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Bruce Westerman, Representative

buy disclosed on 16 Apr 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Marjorie Taylor Mrs Greene, Representative

buy disclosed on 27 Nov 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Daniel Goldman, Representative

sell disclosed on 13 Aug 2023 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

sell disclosed on 4 Apr 2023 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 8 Sept 2022 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 8 Sept 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 8 Sept 2022 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 8 Sept 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 5 Aug 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

sell disclosed on 5 Aug 2022 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Virginia Foxx, Representative

buy disclosed on 4 May 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%